Table 3. Age, gender, age at onset, disease duration, and gadolinium-enhanced lesions in each multiple sclerosis phenotype (n=190).
| Clinical type | Total (%) | Females (%) | Males (%) | Age (years) | Onset age (years) | Disease duration (years) | Patients with gadolinium-enhanced lesion (%) |
|---|---|---|---|---|---|---|---|
| Clinically isolated syndrome | 18 (9.5) | 10 (55.6) | 8 (44.4) | 32.7±10.5 | 28.9±9.0 | 3.72±4.30 | 4 (22.1) |
| Relapsing-remitting multiple sclerosis | 114 (75.8) | 91 (63.2) | 53 (36.8) | 32.0±8.3 | 25.9±7.8 | 5.94±4.60 | 56 (38.9) |
| Secondary progressive multiple sclerosis | 21 (11.1) | 15 (71.4) | 6 (28.6) | 35.6±9.9 | 24.8±9.7 | 10.8±5.2 | 12 (57.1) |
| Primary progressive multiple sclerosis | 7 (3.7) | 2 (28.6) | 5 (71.4) | 39.7±7.4 | 31.0±7.9 | 8.7±7.1 | 2 (28.6) |
Data are n (%) or mean±SD values.